Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medication Errors | 29 | 2022 | 784 | 5.290 |
Why?
|
Medical Order Entry Systems | 23 | 2022 | 522 | 4.740 |
Why?
|
Diagnostic Errors | 18 | 2022 | 1263 | 3.870 |
Why?
|
Drug Prescriptions | 20 | 2023 | 1668 | 3.340 |
Why?
|
Malpractice | 8 | 2022 | 555 | 3.140 |
Why?
|
Ambulatory Care | 14 | 2023 | 2768 | 2.790 |
Why?
|
Primary Health Care | 27 | 2024 | 4652 | 2.420 |
Why?
|
Electronic Prescribing | 7 | 2019 | 114 | 2.020 |
Why?
|
Physicians, Primary Care | 5 | 2024 | 624 | 1.620 |
Why?
|
Delayed Diagnosis | 5 | 2020 | 463 | 1.610 |
Why?
|
Physicians | 15 | 2023 | 4580 | 1.530 |
Why?
|
Burnout, Professional | 5 | 2024 | 701 | 1.530 |
Why?
|
Continuity of Patient Care | 7 | 2021 | 1067 | 1.230 |
Why?
|
Medical Errors | 11 | 2022 | 1255 | 1.170 |
Why?
|
Ambulatory Care Facilities | 4 | 2021 | 927 | 1.160 |
Why?
|
Diagnostic Tests, Routine | 6 | 2024 | 787 | 1.120 |
Why?
|
Communication | 15 | 2022 | 3846 | 1.110 |
Why?
|
Professional Role | 4 | 2023 | 309 | 1.110 |
Why?
|
Pharmaceutical Preparations | 8 | 2022 | 1090 | 1.020 |
Why?
|
Electronic Health Records | 19 | 2024 | 4761 | 1.000 |
Why?
|
Decision Support Systems, Clinical | 8 | 2022 | 1162 | 0.920 |
Why?
|
Medical Informatics | 4 | 2023 | 732 | 0.900 |
Why?
|
Medication Systems, Hospital | 5 | 2019 | 154 | 0.890 |
Why?
|
Pharmacists | 4 | 2023 | 258 | 0.890 |
Why?
|
Insurance Claim Reporting | 2 | 2014 | 165 | 0.880 |
Why?
|
Pharmacy and Therapeutics Committee | 3 | 2019 | 9 | 0.870 |
Why?
|
Quality Assurance, Health Care | 9 | 2015 | 2167 | 0.870 |
Why?
|
Quality of Health Care | 15 | 2022 | 4317 | 0.810 |
Why?
|
Respiratory Care Units | 1 | 2021 | 10 | 0.800 |
Why?
|
Safety Management | 7 | 2020 | 760 | 0.750 |
Why?
|
Patient-Centered Care | 6 | 2018 | 1415 | 0.720 |
Why?
|
Telephone | 5 | 2014 | 625 | 0.670 |
Why?
|
Diagnostic Techniques and Procedures | 3 | 2018 | 219 | 0.670 |
Why?
|
Physician-Patient Relations | 8 | 2018 | 3242 | 0.660 |
Why?
|
Humans | 163 | 2024 | 758406 | 0.650 |
Why?
|
Pneumonia, Viral | 3 | 2021 | 3196 | 0.640 |
Why?
|
Appointments and Schedules | 2 | 2021 | 441 | 0.610 |
Why?
|
Decision Making | 5 | 2019 | 3915 | 0.610 |
Why?
|
Knowledge Bases | 1 | 2018 | 97 | 0.600 |
Why?
|
Formularies as Topic | 2 | 2021 | 93 | 0.580 |
Why?
|
Medical Record Linkage | 3 | 2005 | 287 | 0.570 |
Why?
|
Crying | 1 | 2017 | 37 | 0.560 |
Why?
|
Hospitals, Public | 5 | 2011 | 201 | 0.550 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2023 | 1110 | 0.540 |
Why?
|
Disease | 1 | 2022 | 671 | 0.530 |
Why?
|
Terminology as Topic | 3 | 2018 | 1533 | 0.530 |
Why?
|
Memory, Short-Term | 1 | 2022 | 978 | 0.520 |
Why?
|
Awards and Prizes | 1 | 2020 | 359 | 0.510 |
Why?
|
Patient Advocacy | 2 | 2015 | 360 | 0.510 |
Why?
|
Inappropriate Prescribing | 2 | 2016 | 209 | 0.510 |
Why?
|
Colonoscopy | 1 | 2023 | 1388 | 0.510 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 748 | 0.500 |
Why?
|
Staff Development | 1 | 2017 | 229 | 0.490 |
Why?
|
Speech Recognition Software | 3 | 2014 | 74 | 0.490 |
Why?
|
Social Justice | 2 | 2014 | 479 | 0.490 |
Why?
|
Documentation | 8 | 2022 | 892 | 0.480 |
Why?
|
Outpatients | 3 | 2018 | 1591 | 0.470 |
Why?
|
Epidemics | 1 | 2020 | 512 | 0.470 |
Why?
|
Health Personnel | 3 | 2023 | 3312 | 0.470 |
Why?
|
Education, Medical | 4 | 2018 | 1725 | 0.460 |
Why?
|
Risk Management | 1 | 2017 | 557 | 0.450 |
Why?
|
Referral and Consultation | 9 | 2023 | 3586 | 0.450 |
Why?
|
Analgesics, Opioid | 6 | 2024 | 3765 | 0.440 |
Why?
|
Altruism | 1 | 2015 | 205 | 0.430 |
Why?
|
Ethics, Professional | 1 | 2013 | 100 | 0.430 |
Why?
|
Anti-Obesity Agents | 1 | 2016 | 227 | 0.430 |
Why?
|
Diet, Reducing | 1 | 2016 | 485 | 0.430 |
Why?
|
Drug Therapy | 2 | 2009 | 503 | 0.420 |
Why?
|
Professional-Patient Relations | 2 | 2015 | 727 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3076 | 0.420 |
Why?
|
Adverse Drug Reaction Reporting Systems | 4 | 2024 | 488 | 0.400 |
Why?
|
Patient Care Team | 7 | 2022 | 2504 | 0.400 |
Why?
|
Attitude of Health Personnel | 7 | 2019 | 3867 | 0.390 |
Why?
|
Delivery of Health Care | 7 | 2022 | 5331 | 0.390 |
Why?
|
Social Responsibility | 1 | 2014 | 386 | 0.390 |
Why?
|
Software | 3 | 2023 | 4415 | 0.390 |
Why?
|
Workflow | 5 | 2021 | 850 | 0.380 |
Why?
|
Mass Screening | 3 | 2018 | 5427 | 0.370 |
Why?
|
Uncertainty | 4 | 2023 | 751 | 0.370 |
Why?
|
Organizational Policy | 2 | 2010 | 429 | 0.370 |
Why?
|
Clinical Pharmacy Information Systems | 2 | 2003 | 102 | 0.360 |
Why?
|
Counseling | 1 | 2018 | 1541 | 0.360 |
Why?
|
Crowding | 1 | 2011 | 142 | 0.360 |
Why?
|
Prescription Drugs | 3 | 2012 | 626 | 0.350 |
Why?
|
Opioid-Related Disorders | 2 | 2022 | 2142 | 0.350 |
Why?
|
Pharmacies | 4 | 2018 | 163 | 0.350 |
Why?
|
United States | 30 | 2022 | 72136 | 0.350 |
Why?
|
Drug Implants | 1 | 2010 | 230 | 0.340 |
Why?
|
Health Services Misuse | 1 | 2011 | 244 | 0.340 |
Why?
|
Adenoma, Oxyphilic | 1 | 2011 | 148 | 0.330 |
Why?
|
Disease Management | 1 | 2020 | 2500 | 0.330 |
Why?
|
Quality Improvement | 5 | 2019 | 3806 | 0.330 |
Why?
|
Education, Pharmacy | 1 | 2009 | 38 | 0.320 |
Why?
|
Massachusetts | 11 | 2017 | 8823 | 0.310 |
Why?
|
Drug Labeling | 2 | 2017 | 248 | 0.310 |
Why?
|
Data Mining | 1 | 2013 | 551 | 0.310 |
Why?
|
Diagnostic Services | 2 | 2021 | 34 | 0.310 |
Why?
|
Marketing | 1 | 2010 | 220 | 0.310 |
Why?
|
Radiology | 1 | 2022 | 2102 | 0.310 |
Why?
|
Emergency Service, Hospital | 5 | 2018 | 7810 | 0.310 |
Why?
|
Checklist | 2 | 2012 | 827 | 0.300 |
Why?
|
Patient Care | 3 | 2014 | 622 | 0.300 |
Why?
|
Health Care Surveys | 7 | 2017 | 2432 | 0.290 |
Why?
|
Organizational Innovation | 3 | 2019 | 536 | 0.290 |
Why?
|
Weight Loss | 2 | 2016 | 2671 | 0.290 |
Why?
|
Hyperkalemia | 3 | 2016 | 231 | 0.290 |
Why?
|
Reimbursement, Incentive | 1 | 2012 | 540 | 0.290 |
Why?
|
Retrospective Studies | 24 | 2024 | 80168 | 0.280 |
Why?
|
Incidental Findings | 2 | 2013 | 694 | 0.280 |
Why?
|
Models, Theoretical | 1 | 2019 | 3561 | 0.280 |
Why?
|
Chronic Disease | 3 | 2020 | 9267 | 0.280 |
Why?
|
Drug Interactions | 5 | 2018 | 1414 | 0.270 |
Why?
|
Pandemics | 3 | 2021 | 8611 | 0.270 |
Why?
|
Patient Preference | 1 | 2014 | 921 | 0.270 |
Why?
|
Financing, Personal | 2 | 2013 | 309 | 0.270 |
Why?
|
Humanism | 2 | 2019 | 86 | 0.270 |
Why?
|
Health Care Reform | 5 | 2022 | 1245 | 0.260 |
Why?
|
Tablets | 1 | 2006 | 147 | 0.260 |
Why?
|
Adult | 31 | 2024 | 219935 | 0.260 |
Why?
|
Colorectal Neoplasms | 2 | 2017 | 6852 | 0.250 |
Why?
|
Conflict of Interest | 1 | 2010 | 548 | 0.250 |
Why?
|
Qualitative Research | 5 | 2023 | 2976 | 0.250 |
Why?
|
Hospital Administration | 2 | 2017 | 354 | 0.250 |
Why?
|
Middle Aged | 34 | 2024 | 219568 | 0.240 |
Why?
|
Drug Monitoring | 4 | 2016 | 960 | 0.240 |
Why?
|
Emergency Medicine | 3 | 2015 | 1195 | 0.240 |
Why?
|
Hormone Replacement Therapy | 1 | 2010 | 754 | 0.240 |
Why?
|
Clinical Laboratory Information Systems | 2 | 2003 | 108 | 0.240 |
Why?
|
Substance Abuse Detection | 3 | 2024 | 301 | 0.230 |
Why?
|
Thyroid Function Tests | 1 | 2005 | 289 | 0.230 |
Why?
|
Health Policy | 4 | 2018 | 2677 | 0.230 |
Why?
|
Male | 43 | 2024 | 358747 | 0.230 |
Why?
|
Dyspnea | 1 | 2012 | 1344 | 0.230 |
Why?
|
Female | 44 | 2024 | 390323 | 0.220 |
Why?
|
Clinical Competence | 3 | 2009 | 4775 | 0.220 |
Why?
|
Estrogens | 1 | 2010 | 1520 | 0.220 |
Why?
|
Laboratories | 3 | 2021 | 460 | 0.220 |
Why?
|
Hospitals, Proprietary | 2 | 2000 | 39 | 0.220 |
Why?
|
Gemfibrozil | 1 | 2002 | 30 | 0.220 |
Why?
|
Health Services Accessibility | 5 | 2011 | 5404 | 0.210 |
Why?
|
Pharmacy Service, Hospital | 2 | 2010 | 134 | 0.210 |
Why?
|
American Public Health Association | 1 | 2022 | 1 | 0.210 |
Why?
|
Information Dissemination | 2 | 2013 | 1129 | 0.210 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3211 | 0.210 |
Why?
|
Internal Medicine | 1 | 2009 | 1048 | 0.200 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1915 | 0.200 |
Why?
|
Feedback | 2 | 2020 | 791 | 0.200 |
Why?
|
Diagnosis, Differential | 3 | 2023 | 12951 | 0.200 |
Why?
|
Hospitals, Community | 3 | 2013 | 367 | 0.200 |
Why?
|
Single-Payer System | 1 | 2022 | 35 | 0.200 |
Why?
|
Internship and Residency | 5 | 2023 | 5865 | 0.200 |
Why?
|
Thyroxine | 1 | 2005 | 667 | 0.190 |
Why?
|
Patient Education as Topic | 3 | 2018 | 2307 | 0.190 |
Why?
|
Public Health | 1 | 2014 | 2658 | 0.190 |
Why?
|
Social Identification | 1 | 2021 | 107 | 0.180 |
Why?
|
Truth Disclosure | 1 | 2005 | 432 | 0.180 |
Why?
|
Systems Analysis | 1 | 2021 | 169 | 0.180 |
Why?
|
Publications | 1 | 2023 | 194 | 0.180 |
Why?
|
Medically Underserved Area | 1 | 2003 | 257 | 0.180 |
Why?
|
Medical Records Systems, Computerized | 6 | 2019 | 1190 | 0.180 |
Why?
|
Patient Participation | 3 | 2021 | 1436 | 0.180 |
Why?
|
Chromatography, Liquid | 2 | 2021 | 986 | 0.170 |
Why?
|
Health Services for the Aged | 1 | 2002 | 259 | 0.170 |
Why?
|
Hospitals, Voluntary | 1 | 2000 | 38 | 0.170 |
Why?
|
Hypothyroidism | 1 | 2005 | 665 | 0.170 |
Why?
|
False Positive Reactions | 2 | 2020 | 956 | 0.170 |
Why?
|
Computers | 1 | 2002 | 596 | 0.170 |
Why?
|
Muscle Weakness | 1 | 2002 | 413 | 0.170 |
Why?
|
False Negative Reactions | 1 | 2020 | 573 | 0.170 |
Why?
|
Cooperative Behavior | 5 | 2017 | 1501 | 0.170 |
Why?
|
Medical Audit | 2 | 2017 | 452 | 0.160 |
Why?
|
Community Health Centers | 1 | 2003 | 461 | 0.160 |
Why?
|
Hospitalists | 1 | 2003 | 294 | 0.160 |
Why?
|
User-Computer Interface | 3 | 2022 | 1397 | 0.160 |
Why?
|
Pharmacy | 1 | 2000 | 92 | 0.160 |
Why?
|
Anthropology, Cultural | 1 | 2019 | 102 | 0.160 |
Why?
|
Urinalysis | 1 | 2021 | 368 | 0.160 |
Why?
|
Absorptiometry, Photon | 1 | 2005 | 1735 | 0.160 |
Why?
|
Organizational Case Studies | 3 | 2017 | 301 | 0.160 |
Why?
|
Patient Simulation | 2 | 2013 | 297 | 0.160 |
Why?
|
Hospitals, Teaching | 3 | 2015 | 1159 | 0.150 |
Why?
|
Hypolipidemic Agents | 1 | 2002 | 609 | 0.150 |
Why?
|
Insurance, Health | 2 | 2008 | 2495 | 0.150 |
Why?
|
Aged | 20 | 2024 | 168218 | 0.150 |
Why?
|
Leadership | 2 | 2017 | 1371 | 0.150 |
Why?
|
Ecosystem | 1 | 2022 | 487 | 0.150 |
Why?
|
Drug Utilization | 2 | 2016 | 1187 | 0.150 |
Why?
|
Insurance Carriers | 2 | 2022 | 155 | 0.140 |
Why?
|
Forecasting | 3 | 2023 | 2923 | 0.140 |
Why?
|
Patient Identification Systems | 1 | 2017 | 75 | 0.140 |
Why?
|
Interprofessional Relations | 2 | 2015 | 989 | 0.140 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2016 | 87 | 0.140 |
Why?
|
Medication Adherence | 3 | 2018 | 2155 | 0.140 |
Why?
|
Cation Exchange Resins | 1 | 2016 | 19 | 0.140 |
Why?
|
Pyridines | 2 | 2012 | 2859 | 0.140 |
Why?
|
Potassium | 1 | 2000 | 1310 | 0.130 |
Why?
|
Medication Reconciliation | 1 | 2018 | 153 | 0.130 |
Why?
|
Polystyrenes | 1 | 2016 | 104 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2017 | 3992 | 0.130 |
Why?
|
Self Report | 2 | 2019 | 3714 | 0.130 |
Why?
|
Osteoporosis | 1 | 2005 | 1598 | 0.120 |
Why?
|
Patient Satisfaction | 3 | 2014 | 3446 | 0.120 |
Why?
|
Telemedicine | 2 | 2023 | 3018 | 0.120 |
Why?
|
Pain | 2 | 2016 | 5065 | 0.120 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2017 | 389 | 0.120 |
Why?
|
Time Factors | 4 | 2023 | 39872 | 0.120 |
Why?
|
National Health Insurance, United States | 1 | 1994 | 100 | 0.120 |
Why?
|
Neoplasms | 3 | 2024 | 22032 | 0.120 |
Why?
|
Access to Information | 1 | 2017 | 319 | 0.120 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4312 | 0.120 |
Why?
|
Obesity | 1 | 2016 | 12870 | 0.110 |
Why?
|
Academic Medical Centers | 6 | 2023 | 2751 | 0.110 |
Why?
|
Education, Medical, Continuing | 1 | 2019 | 827 | 0.110 |
Why?
|
Feedback, Psychological | 1 | 2014 | 95 | 0.110 |
Why?
|
Administrative Personnel | 1 | 2015 | 182 | 0.110 |
Why?
|
Databases, Factual | 4 | 2019 | 7980 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5199 | 0.110 |
Why?
|
Reference Standards | 1 | 2017 | 1003 | 0.110 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1186 | 0.110 |
Why?
|
Forms and Records Control | 1 | 1994 | 158 | 0.110 |
Why?
|
Models, Organizational | 2 | 2011 | 546 | 0.110 |
Why?
|
Chicago | 5 | 2019 | 254 | 0.110 |
Why?
|
Data Collection | 4 | 2022 | 3322 | 0.110 |
Why?
|
Personnel, Hospital | 1 | 2015 | 285 | 0.100 |
Why?
|
Total Quality Management | 1 | 1994 | 264 | 0.100 |
Why?
|
Dermatology | 1 | 2022 | 914 | 0.100 |
Why?
|
Boston | 2 | 2023 | 9304 | 0.100 |
Why?
|
Interdisciplinary Communication | 2 | 2015 | 931 | 0.100 |
Why?
|
Drugs, Generic | 1 | 2017 | 444 | 0.100 |
Why?
|
Cognition | 2 | 2022 | 6953 | 0.100 |
Why?
|
Gentian Violet | 1 | 1991 | 26 | 0.100 |
Why?
|
Phenazines | 1 | 1991 | 56 | 0.100 |
Why?
|
Product Labeling | 1 | 2012 | 76 | 0.100 |
Why?
|
Bone Density | 1 | 2005 | 3533 | 0.100 |
Why?
|
Diagnosis-Related Groups | 2 | 2014 | 449 | 0.100 |
Why?
|
Inpatients | 3 | 2022 | 2551 | 0.100 |
Why?
|
Ambulatory Care Information Systems | 1 | 2011 | 88 | 0.090 |
Why?
|
Job Satisfaction | 1 | 2015 | 539 | 0.090 |
Why?
|
Theophylline | 1 | 1991 | 131 | 0.090 |
Why?
|
Insurance Coverage | 1 | 2002 | 1933 | 0.090 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2019 | 932 | 0.090 |
Why?
|
Pilot Projects | 4 | 2014 | 8553 | 0.090 |
Why?
|
Systems Integration | 3 | 2013 | 426 | 0.090 |
Why?
|
Program Development | 1 | 2017 | 1298 | 0.090 |
Why?
|
Regional Medical Programs | 1 | 2011 | 67 | 0.090 |
Why?
|
Health Services Research | 3 | 2022 | 1812 | 0.090 |
Why?
|
Prostatic Neoplasms | 1 | 2013 | 11336 | 0.090 |
Why?
|
Hospitals | 3 | 2011 | 3887 | 0.090 |
Why?
|
Natural Language Processing | 1 | 2019 | 1134 | 0.090 |
Why?
|
Nicotinic Agonists | 1 | 2012 | 265 | 0.090 |
Why?
|
Quinoxalines | 1 | 2012 | 297 | 0.090 |
Why?
|
Benzazepines | 1 | 2012 | 310 | 0.090 |
Why?
|
Remote Consultation | 1 | 2013 | 234 | 0.090 |
Why?
|
Canada | 1 | 2015 | 2111 | 0.090 |
Why?
|
Students, Medical | 2 | 2018 | 1927 | 0.090 |
Why?
|
Utah | 2 | 2000 | 131 | 0.090 |
Why?
|
Colorado | 2 | 2000 | 164 | 0.090 |
Why?
|
Needs Assessment | 1 | 2015 | 1141 | 0.080 |
Why?
|
Prospective Studies | 5 | 2023 | 54137 | 0.080 |
Why?
|
Physician's Role | 2 | 2015 | 917 | 0.080 |
Why?
|
Sputum | 1 | 1991 | 502 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2010 | 7818 | 0.080 |
Why?
|
Medicare | 2 | 2008 | 6741 | 0.080 |
Why?
|
United States Food and Drug Administration | 1 | 2017 | 1659 | 0.080 |
Why?
|
Hospitalization | 4 | 2016 | 10652 | 0.080 |
Why?
|
Young Adult | 9 | 2018 | 58808 | 0.080 |
Why?
|
Reminder Systems | 2 | 2018 | 387 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20055 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3526 | 0.080 |
Why?
|
Spinal Stenosis | 1 | 2011 | 262 | 0.070 |
Why?
|
Iatrogenic Disease | 1 | 1991 | 538 | 0.070 |
Why?
|
Algorithms | 3 | 2019 | 13961 | 0.070 |
Why?
|
Hypnotics and Sedatives | 2 | 2013 | 1176 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2002 | 3227 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2013 | 809 | 0.070 |
Why?
|
Hospital Information Systems | 1 | 1990 | 393 | 0.070 |
Why?
|
Professional Practice | 1 | 2009 | 313 | 0.070 |
Why?
|
Medical Records | 2 | 1990 | 1406 | 0.070 |
Why?
|
Anti-Bacterial Agents | 3 | 2022 | 7403 | 0.070 |
Why?
|
Staphylococcal Infections | 2 | 2010 | 1406 | 0.070 |
Why?
|
Staining and Labeling | 1 | 1991 | 1083 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14641 | 0.070 |
Why?
|
Cross-Sectional Studies | 5 | 2015 | 25956 | 0.070 |
Why?
|
Unnecessary Procedures | 1 | 2010 | 411 | 0.070 |
Why?
|
Appendectomy | 1 | 2010 | 431 | 0.070 |
Why?
|
Aged, 80 and over | 7 | 2018 | 58683 | 0.070 |
Why?
|
Medically Uninsured | 2 | 2003 | 836 | 0.070 |
Why?
|
Naproxen | 1 | 2006 | 100 | 0.060 |
Why?
|
Evaluation Studies as Topic | 2 | 2001 | 1628 | 0.060 |
Why?
|
Curriculum | 1 | 2019 | 3717 | 0.060 |
Why?
|
Product Surveillance, Postmarketing | 1 | 1990 | 451 | 0.060 |
Why?
|
Lorazepam | 1 | 2006 | 154 | 0.060 |
Why?
|
Drug Costs | 1 | 2013 | 1178 | 0.060 |
Why?
|
Cohort Studies | 3 | 2018 | 41256 | 0.060 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2010 | 706 | 0.060 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2005 | 92 | 0.060 |
Why?
|
Research | 1 | 2013 | 1976 | 0.060 |
Why?
|
Cholera | 3 | 2001 | 747 | 0.060 |
Why?
|
Vibrio cholerae | 2 | 2001 | 793 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8530 | 0.060 |
Why?
|
Medical History Taking | 1 | 2008 | 772 | 0.060 |
Why?
|
Population Surveillance | 1 | 2015 | 2606 | 0.060 |
Why?
|
Mammography | 1 | 2015 | 2427 | 0.060 |
Why?
|
Blood Specimen Collection | 1 | 2005 | 238 | 0.060 |
Why?
|
Drug Industry | 1 | 2010 | 787 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2011 | 1402 | 0.060 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 694 | 0.060 |
Why?
|
Vancomycin | 2 | 2010 | 503 | 0.060 |
Why?
|
Simvastatin | 1 | 2006 | 351 | 0.060 |
Why?
|
Observer Variation | 1 | 2009 | 2600 | 0.050 |
Why?
|
Appendicitis | 1 | 2010 | 674 | 0.050 |
Why?
|
Occult Blood | 1 | 2004 | 198 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2021 | 22029 | 0.050 |
Why?
|
Medical Oncology | 1 | 2015 | 2312 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39059 | 0.050 |
Why?
|
Blood | 1 | 2005 | 586 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2022 | 5797 | 0.050 |
Why?
|
Anecdotes as Topic | 1 | 2002 | 56 | 0.050 |
Why?
|
Tape Recording | 1 | 2022 | 75 | 0.050 |
Why?
|
Income Tax | 1 | 2002 | 24 | 0.050 |
Why?
|
Government Agencies | 1 | 2002 | 160 | 0.050 |
Why?
|
Information Systems | 2 | 2016 | 397 | 0.050 |
Why?
|
Medicaid | 2 | 2008 | 2807 | 0.050 |
Why?
|
Capitation Fee | 1 | 2001 | 116 | 0.050 |
Why?
|
Adolescent | 9 | 2018 | 87892 | 0.050 |
Why?
|
Cancer Care Facilities | 1 | 2024 | 424 | 0.050 |
Why?
|
Vancomycin Resistance | 1 | 2001 | 126 | 0.050 |
Why?
|
Creatine Kinase | 1 | 2002 | 686 | 0.050 |
Why?
|
Prevalence | 2 | 2015 | 15651 | 0.050 |
Why?
|
Cholera Vaccines | 2 | 2001 | 262 | 0.040 |
Why?
|
Autopsy | 1 | 1984 | 1003 | 0.040 |
Why?
|
Nursing Service, Hospital | 1 | 2000 | 16 | 0.040 |
Why?
|
Lebanon | 1 | 2001 | 245 | 0.040 |
Why?
|
Administration, Oral | 2 | 2006 | 3991 | 0.040 |
Why?
|
Hospitals, County | 1 | 1980 | 17 | 0.040 |
Why?
|
Reading | 1 | 2024 | 529 | 0.040 |
Why?
|
Patient Discharge | 2 | 1990 | 3433 | 0.040 |
Why?
|
Veterans Health | 1 | 2022 | 215 | 0.040 |
Why?
|
Treatment Refusal | 1 | 2003 | 429 | 0.040 |
Why?
|
Exercise | 1 | 2016 | 5788 | 0.040 |
Why?
|
Health Priorities | 1 | 2003 | 375 | 0.040 |
Why?
|
Antibodies, Bacterial | 3 | 2001 | 1468 | 0.040 |
Why?
|
Health Care Sector | 1 | 2001 | 194 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2013 | 20500 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2001 | 319 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2002 | 419 | 0.040 |
Why?
|
Heart Failure | 1 | 2003 | 11593 | 0.040 |
Why?
|
Interdepartmental Relations | 1 | 1998 | 13 | 0.040 |
Why?
|
Health Expenditures | 1 | 2011 | 2347 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2001 | 856 | 0.040 |
Why?
|
Drug Information Services | 1 | 1998 | 51 | 0.040 |
Why?
|
Risk Assessment | 4 | 2016 | 23884 | 0.040 |
Why?
|
Midwestern United States | 1 | 2017 | 68 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2021 | 600 | 0.040 |
Why?
|
Ownership | 1 | 2000 | 339 | 0.040 |
Why?
|
Communicable Diseases | 1 | 2005 | 877 | 0.040 |
Why?
|
Guideline Adherence | 2 | 2011 | 2215 | 0.030 |
Why?
|
Proton Pump Inhibitors | 1 | 2022 | 529 | 0.030 |
Why?
|
Computer Systems | 1 | 1998 | 470 | 0.030 |
Why?
|
Fee-for-Service Plans | 1 | 2001 | 701 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 1980 | 385 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1177 | 0.030 |
Why?
|
Carcinoma, Renal Cell | 1 | 2011 | 3217 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2022 | 1130 | 0.030 |
Why?
|
Patient Admission | 1 | 2003 | 1372 | 0.030 |
Why?
|
Logistic Models | 3 | 2017 | 13276 | 0.030 |
Why?
|
Phonetics | 1 | 2016 | 198 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2690 | 0.030 |
Why?
|
Infant | 1 | 2017 | 36055 | 0.030 |
Why?
|
Regression Analysis | 2 | 2016 | 6354 | 0.030 |
Why?
|
Management Quality Circles | 1 | 1994 | 20 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 918 | 0.030 |
Why?
|
Australia | 1 | 2017 | 1276 | 0.030 |
Why?
|
Clinical Audit | 1 | 2013 | 30 | 0.030 |
Why?
|
Workload | 1 | 2019 | 847 | 0.030 |
Why?
|
Cholecystitis, Acute | 1 | 2013 | 74 | 0.030 |
Why?
|
Alabama | 1 | 2013 | 106 | 0.030 |
Why?
|
History, 20th Century | 1 | 2001 | 2772 | 0.030 |
Why?
|
Income | 1 | 2001 | 1872 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2004 | 2523 | 0.030 |
Why?
|
Pelvic Neoplasms | 1 | 2013 | 248 | 0.020 |
Why?
|
Narcotics | 1 | 2013 | 336 | 0.020 |
Why?
|
Auditory Perception | 1 | 2016 | 580 | 0.020 |
Why?
|
Incidence | 1 | 2009 | 21272 | 0.020 |
Why?
|
Poverty | 1 | 2003 | 2692 | 0.020 |
Why?
|
Attitude to Computers | 1 | 2011 | 195 | 0.020 |
Why?
|
World Health Organization | 1 | 2016 | 1312 | 0.020 |
Why?
|
Daptomycin | 1 | 2010 | 71 | 0.020 |
Why?
|
Education, Medical, Graduate | 1 | 2022 | 2359 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2017 | 2676 | 0.020 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2011 | 198 | 0.020 |
Why?
|
Oxazolidinones | 1 | 2010 | 97 | 0.020 |
Why?
|
Angioedema | 1 | 2011 | 192 | 0.020 |
Why?
|
Poisoning | 1 | 1991 | 252 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2697 | 0.020 |
Why?
|
Patient Isolation | 1 | 2010 | 100 | 0.020 |
Why?
|
Interinstitutional Relations | 1 | 2011 | 236 | 0.020 |
Why?
|
Perception | 1 | 2016 | 1197 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2015 | 907 | 0.020 |
Why?
|
Freezing | 2 | 2001 | 306 | 0.020 |
Why?
|
Minocycline | 1 | 2010 | 168 | 0.020 |
Why?
|
Palliative Care | 1 | 2024 | 3570 | 0.020 |
Why?
|
Acetamides | 1 | 2010 | 255 | 0.020 |
Why?
|
Child | 1 | 2017 | 79818 | 0.020 |
Why?
|
Hypotension, Orthostatic | 1 | 2011 | 256 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2017 | 14490 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2011 | 694 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 1989 | 11424 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2015 | 21017 | 0.020 |
Why?
|
Risk Factors | 2 | 2011 | 73809 | 0.020 |
Why?
|
Delphi Technique | 1 | 2011 | 829 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2013 | 1063 | 0.020 |
Why?
|
Politics | 1 | 1994 | 815 | 0.020 |
Why?
|
Commerce | 1 | 2012 | 604 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15225 | 0.020 |
Why?
|
Memory | 1 | 2016 | 2179 | 0.020 |
Why?
|
Patients | 1 | 2012 | 904 | 0.020 |
Why?
|
Community Health Services | 1 | 2011 | 656 | 0.020 |
Why?
|
Diabetes Mellitus | 2 | 2014 | 5816 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1503 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2010 | 1436 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2001 | 7378 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1386 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 36284 | 0.010 |
Why?
|
Accidental Falls | 1 | 2011 | 1056 | 0.010 |
Why?
|
Diagnosis | 1 | 1984 | 156 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7021 | 0.010 |
Why?
|
Hip Fractures | 1 | 2011 | 987 | 0.010 |
Why?
|
Infection Control | 1 | 2010 | 982 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4901 | 0.010 |
Why?
|
Quality Control | 1 | 2005 | 825 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 1990 | 1780 | 0.010 |
Why?
|
Databases as Topic | 1 | 2004 | 472 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2016 | 0.010 |
Why?
|
Colony Count, Microbial | 1 | 2001 | 328 | 0.010 |
Why?
|
Serotyping | 1 | 2001 | 324 | 0.010 |
Why?
|
Thailand | 1 | 2001 | 288 | 0.010 |
Why?
|
Specialization | 1 | 2005 | 776 | 0.010 |
Why?
|
Educational Measurement | 1 | 2007 | 1248 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2007 | 12262 | 0.010 |
Why?
|
Illinois | 1 | 1980 | 118 | 0.010 |
Why?
|
Coronary Disease | 1 | 2013 | 5917 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12096 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1984 | 2359 | 0.010 |
Why?
|
Medicine | 1 | 2005 | 942 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2013 | 4876 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3175 | 0.010 |
Why?
|
Cholera Toxin | 1 | 1998 | 559 | 0.010 |
Why?
|
Feces | 1 | 2001 | 1456 | 0.010 |
Why?
|
Research Design | 1 | 2011 | 6157 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1998 | 979 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6362 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18358 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 2001 | 1755 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 64378 | 0.010 |
Why?
|
Hypertension | 1 | 2011 | 8499 | 0.010 |
Why?
|
Vaccination | 1 | 1999 | 3355 | 0.000 |
Why?
|
Immunoglobulin G | 1 | 1998 | 4540 | 0.000 |
Why?
|
Models, Biological | 1 | 2001 | 9460 | 0.000 |
Why?
|